Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis

• Published in: Journal of internal medicine Vol. 292; no. 5; pp. 745 - 763
• Main Authors: Jakobsson, Per‐Johan, Robertson, Luke, Welzel, Janika, Zhang, Mingshu, Zhihua, Yang, Kaixin, Gao, Runyue, Huang, Zehuai, Wen, Korotkova, Marina, Göransson, Ulf
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.11.2022
• Subjects: Alleles; Antibodies; Arthritis; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - prevention & control; Autoantibodies; Chinese medicine; Citrulline; Clinical trials; Clinical Trials as Topic; Drb1 protein; Drugs, Chinese Herbal - therapeutic use; Epitopes; Epitopes - genetics; Genetic Predisposition to Disease; Herbal medicine; Histocompatibility antigen HLA; HLA-DRB1 Chains - genetics; Humans; inflammation; Joint diseases; Medicin och hälsovetenskap; Medicinal plants; Medicine, Chinese Traditional; Peptides; Prevention; Proteins; Rheumatoid arthritis; Rheumatoid factor; Rheumatoid Factor - genetics; Tea; Traditional Chinese medicine; inflammation; traditional Chinese medicine; rheumatoid arthritis

Chinese medicine has a long tradition of use against rheumatoid arthritis (RA). The formulations are based on combinations of typically 5–10 plants, which are usually boiled and administered as a decoction or tea. There are few clinical trials performed so the clinical evidence is sparse. One fundam...